CRVS Corvus Pharmaceuticals, Inc.
$12.91▼ -0.23%
Healthcare
Other
After hours
$12.91▲ +0.00%
Sep 11, 7:30 PM ET
Volume 1.26M
Avg Volume (10D) 791.5K
Key Metrics & Fundamentals
Market Cap
$1.09B
P/E Ratio
–
Div Yield
–%
52W Range
5.64 - 26.95
% vs 50 MA
-9.87%
% vs 200 MA
-7.05%
RSI-14
35.9
MACD Histogram
-0.2000
Beta (1Y vs SPY)
-0.43
Free Cash Flow
-$15.98M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$19.26M
COGS
–
Operating Exp
$19.30M
Operating Income
-$19.30M
EBIT
-$19.30M
Pretax Income
-$17.96M
Net Income
-$17.96M
EPS (Diluted)
-0.19
Price & Volume History
Loading chart…
Recent News
Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference
GlobeNewswire · Sep 3, 2026 12:30 PM
Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial
GlobeNewswire · Aug 27, 2026 11:30 AM
Corvus Pharmaceuticals (CRVS): This Clinical-Stage Drugmaker Just Got A Lot More Interesting
Insider Monkey · Aug 17, 2026 3:16 PM
Corvus Pharmaceuticals (CRVS) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 14, 2026 3:42 PM
Corvus Pharmaceuticals Inc (CRVS) (Q2 2026) Earnings Call Highlights: Advancing Soquelitinib ...
GuruFocus.com · Aug 7, 2026 5:09 AM
Corvus Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 7, 2026 3:43 AM
Corvus Pharmaceuticals Q2 Earnings Call Highlights
MarketBeat · Aug 7, 2026 12:03 AM
Corvus: Q2 Earnings Snapshot
Associated Press · Aug 6, 2026 8:36 PM
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 6, 2026 8:01 PM
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026
GlobeNewswire · Jul 30, 2026 8:01 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CRVS's money flow as a full page
Social Sentiment
Avg +0.80 · 2 posts
NewsDiscussionDDCorvus Pharmaceuticals (CRVS)
r/wallstreetbets · Feb 15, 2026
The post discusses positive Phase 1 data and potential for future growth, indicating bullish sentiment.
positive
+0.80
NewsDiscussionTradeCRVS nearly doubles in hours — did retail drive this?
r/wallstreetbets · Jan 21, 2026
Significant price increase and discussion of retail interest indicates positive sentiment.
positive
+0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.